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Expression of the Autoimmune regulator (AIRE) outside of the thymus has long been
suggested in both humans and mice, but the cellular source in humans has remained
undefined. Here we identify AIRE expression in human tonsils and extensively analyzed
these “extra-thymic AIRE expressing cells” (eTACs) using combinations of flow cytometry,
CyTOF and single cell RNA-sequencing. We identified AIRE+ cells as dendritic cells
(DCs) with a mature and migratory phenotype including high levels of antigen presenting
molecules and costimulatory molecules, and specific expression of CD127, CCR7,
and PDL1. These cells also possessed the ability to stimulate and re-stimulate T cells
and displayed reduced responses to toll-like receptor (TLR) agonists compared to
conventional DCs. While expression of AIRE was enriched within CCR7+CD127+ DCs,
single-cell RNA sequencing revealed expression of AIRE to be transient, rather than
stable, and associated with the differentiation to a mature phenotype. The role of AIRE
in central tolerance induction within the thymus is well-established, however our study
shows that AIRE expression within the periphery is not associated with an enriched
expression of tissue-restricted antigens (TRAs). This unexpected finding, suggestive of
wider functions of AIRE, may provide an explanation for the non-autoimmune symptoms
of APECED patients who lack functional AIRE.
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INTRODUCTION
Autoimmune regulator (AIRE) has primarily received
attention due to its expression within the thymus and role
in tolerance induction. Two parallel observations led to the
identification of AIRE as a master regulator of central tolerance;
firstly the presence of transcripts for peripheral antigens
within the thymus (1) and secondly the identification of a
genetic locus with transcriptional activity responsible for the
multi-organ autoimmune disease, known as autoimmune
polyendocrinopathy candidiasis ectodermal dystrophy
(APECED) (2–5). A seminal study by Anderson et al. (6)
provided the link between these observations. Using AIRE-
deficient mice this study demonstrated the role of AIRE in
promoting tissue-specific gene expression within the thymus
and a related reduction in the self-reactivity of peripheral
T cells. Expression of AIRE and associated tissue restricted
antigens (TRAs) are largely restricted to a specific population of
epithelial cells within the medulla (mTEC) (1), where developing
thymocytes are screened for self-reactivity and deleted before
release into the periphery. Together, these findings established
thymic AIRE as the master transcription factor for central
tolerance induction during T cell development.
Several reports have also detected expression of AIRE outside
the thymus (3, 6). However, reports have been conflicting
and the cellular source controversial, with reports in both
stromal (7, 8) and hematopoetic (9–11) populations. Recently,
a population of AIRE expressing cells within the secondary
lymphoid organs of mice were identified (12). These cells
were bone marrow-derived yet with low surface CD45 levels,
potentially reconciling reports of AIRE expression in both
stromal and hematopoetic lineages. These AIRE-expressing cells
formed a distinct Major Histocompatibility Class II (MHCII)hi
antigen presenting population with the ability to functionally
inactivate CD4+ T cells (12). However, the existence of a
corresponding extra-thymic AIRE expressing cell (eTAC) in
humans has yet to be firmly established, or the identity of such
cells described. Here, we demonstrate AIRE to be expressed
outside the human thymus, and extensively characterize these
cells within human lymphoid organs. We find these cells to be
CD127+ DCs with a mature CCR7+PDL1+ phenotype that
express AIRE during their maturation.
RESULTS
Extra-Thymic Expression of AIRE in Human
Tonsil
By confocal imaging AIRE expressing cells could be identified
within human peripheral tonsil tissue (Figure 1A) in addition
to those within the human thymus, which has been well-
defined (Supplementary Figure 1A). These extra-thymic AIRE
positive cells of the tonsil were localized within the T cell
zone, at the boundary between the T cell paracortex and B cell
follicles. eTACs have previously been described in mice as a bone
marrow-derived CD45+ and MHCII+ APC population which
expresses the epithelial marker EpCAM (12). To identify the
potential human equivalents of eTACs in mice we performed
a screen of 33 surface markers using Cytometry by Time-of-
Flight (CyTOF). Given the low levels of AIRE expression in
the periphery (6, 7), and the failure of in-house conjugated
AIRE antibodies to detect AIRE (data not shown), the panel was
designed to include those surface markers which define mouse
eTACs, and other innate and antigen-presenting cell types. With
t-distributed stochastic neighbor embedding (t-SNE) of all tonsil
CD45+MHCII+ cells, and by using color as a third dimension to
visualize the intensity of expression of specific markers, distinct
clusters relating to conventional dendritic cells (CD11c; cDC)
and plasmacytoid dendritic cells (CD123; pDC) were clearly
visible (Figures 1B,C). Mouse eTACs have previously been
characterized by high expression of EpCAM amongst MHCII+
leukocytes; (12) therefore, we used EpCAM expression to identify
a third cluster on the t-SNE plot putatively representing human
eTACs. These cells shared expression of markers with both
cDC and pDC, but uniquely displayed expression of CD127
(Figure 1C).
Therefore, we initially defined human eTACs as
CD45+MHCII+CD40+CD127+EpCAM+. To determine
whether this cluster represented the human equivalent of mouse
eTACs, and to characterize this population further, we sorted
these cells from 2 human tonsils (Supplementary Figure 1B) for
expression profiling by single-cell RNA-sequencing. Comparison
of the distribution in sequencing depth per cell for each
donor showed no systemic differences between the 2 donors
(Supplementary Figure 1C).
We detected abundant mRNA for IL7RA (CD127), HLA
class II loci and the associated CD74, and CD40. Intriguingly,
transcripts for EpCAM were detected in only 4/217 (1.8%) cells.
AIRE mRNA was variably expressed, and restricted to only
a small proportion of cells (25/217 cells; 11.5%) (Figure 1D);
indicating the potential for a more refined phenotype to
capture these cells. To identify cells with the greatest AIRE
expression the high dimensional transcriptomes of donor cells
were embedded into 2 dimensions using t-SNE, which revealed
the appearance of 2 clusters. Cells were computationally assigned
to distinct groups using hierarchical clustering (Figure 1E).
These clusters did not correspond to the individual donors, as
the 2 donors were uniformly represented across both clusters
(Supplementary Figure 1D). AIRE expression was primarily
restricted to the smaller group of cells (Figure 1F –blue
cells). To focus on reliable surface markers for these AIRE-
expressing cells, we then performed differential expression
testing between these 2 clusters (Supplementary Figures 1E,F).
Of the genes that were robustly differentially expressed between
the AIRE-enriched cluster and the remaining cells, CCR7
was most specifically and strongly up-regulated (Figures 1F,G
and Supplementary Figure 1F). In addition we noted that the
inhibitory receptor PDL1 was also enriched in these cells, while
CD11c was relatively down-regulated, as illustrated in Figure 1G.
AIRE Is Expressed by a CD45+ DC
Population Expressing CCR7
We subsequently used these clustering and gene expression
findings to develop a FACS-based gating strategy for the
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FIGURE 1 | Extrathymic AIRE expressing cells are present in human tonsil. (A) Human tonsil sections stained by immunofluorescence for DAPI (blue), AIRE (red), and
CD19 (green). The dashed line indicates the border of the lymphoid follicle (Fo) and scale bars indicating 200µM (left) or 20µM (right) are shown; representative of 2
(Continued)
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FIGURE 1 | donors tested. (B) t-SNE analysis of all HLA-DR+ CD45+ cells from pooled human tonsils (n = 2) generated by considering all 33 markers measured,
shown as a contour plot (C) t-SNE analysis as in (B) colored according to the intensity of expression of CD123, EpCAM, and CD11c. Heatmap indicates the log2 ratio
of means for each marker normalized to the minimum cluster expression (row minimum) according to the specific cell clusters identified and indicated in (B)
(D) CD45+MHCII+CD40+CD127+EpCAM+ cells were sequenced as single cells and log2 normalized transcript levels of sorting markers and AIRE are shown
(E) t-SNE analysis of highly variable genes as measured by RNA-Seq across both donors revealing 2 distinct clusters; cluster 1 (blue dots) and cluster 2 (orange)
(F) Log2 normalized transcript expression levels for AIRE and for defining markers CD45 (PTPRC), CD74, MHCII (HLA-DPB1, HLA-DQA1, HLA-DQB1, HLA-DRB1),
CD40, CD127 (IL7R), CD11c (ITGAX) as well as CCR7 and PDL1 according to the clusters identified (G) Expression levels of CCR7, PDL1 (CD274), and CD11c
(ITGAX) transcripts per cell overlaid on the t-SNE plot. See also Supplementary Figure 1.
identification of AIRE-expressing cells (Figure 2A). With the
exclusion of other cell types using an extensive lineage
cocktail, CCR7+ cells that expressed intermediate levels of
CD11c could be identified amongst MHCII+ antigen-presenting
cells. This population was distinct from cDCs but found
at a much lower frequency (eTACs 0.08 ± 0.1% vs. cDCs
1.344 ± 0.4%). These cells remained uniquely CD127 positive
and expressed cDCs (Figure 2B), although at lower levels
than cDCs, (Figure 2B), in addition to expressing PDL1
(Figure 2C). This was therefore concordant with results from
our single-cell RNA-sequencing experiment. Transcripts for
AIRE within this sorted population were highly enriched,
with greater enrichment than seen in the original population
sorted on EpCAM (Supplementary Figure 2A). Expression was
variable between donors; nevertheless we observed ∼100-
fold greater expression compared to cDC. However, these
levels still represent an order of magnitude lower than those
observed in mTECs (Figure 2D, gating strategy shown in
Supplementary Figure 2B). Henceforward we use the term
eTAC to denote this extra-thymic AIRE-enriched cell population
of CCR7+CD127+MHCII+ cells.
By the same gating strategy, a population of Lin–
CD127+MHCII+CCR7+ cells, which were enriched for
AIRE mRNA, were identified within the postnatal thymus
(Supplementary Figure 2C). These CD45+ cells were distinct
from mTEC, and displayed a similar phenotype to AIRE-
enriched cells within the tonsil, including expression of PDL1
(Supplementary Figures 2D–G).
Detailed phenotypic analysis of this CCR7+ AIRE-enriched
population within tonsils demonstrated the absence of classical
monocyte markers CD68, CD16, CD14, and CD11b at the
protein level (Figure 2E). These cells were likewise negative
for CD123, a marker of pDCs, but did express low levels
of BDCA2 protein (Figure 2F). The greatest similarity, based
on protein marker expression, was with cDCs. AIRE-enriched
cells expressed several markers associated with dendritic cells
in addition to CD11c, including CD4. Both CD26 and CD1c
were expressed, previously described as markers of distinct DC
subsets, together with low levels of BDCA3 (Figure 2G).
We further assayed, by qPCR, transcription factors associated
with dendritic cell populations. pDC-specific transcription
factors E2-2 and IRF8 were absent in the AIRE-enriched cells,
while both IRF4 and BATF3 were expressed at low levels
(Figure 2H).
To determine their morphology and intracellular organelles,
we visualized AIRE-enriched eTACs, pDCs, and cDCs, by
electron microscopy. cDCs displayed large numbers of filopodia,
associated with their role as phagocytic cells, while the rounded
cell surface of eTACs was more similar to pDCs (Figure 2I).
However, pDCs on average contained more multivesicular
bodies, while eTACs and cDCs showed similar levels of
mitochondria and lipid bodies (Supplementary Figure 3A),
indicative of a metabolically active state. Further, eTACs
displayed a propensity for more open chromatin, required for
active gene transcription, which was also evident from reduced
DAPI staining (Supplementary Figures 3B,C).
AIRE Is Not Associated With Tissue
Restricted Antigen Expression in the
Periphery
Based on the enrichment of AIRE in these CCR7+ cells and
the known role of AIRE in promiscuous expression of tissue-
restricted antigen (TRA) genes in mTECs, we examined the
transcriptomes of eTACs with respect to TRAs. As TRAs are
transcribed stochastically and at low cell frequency (13), we
sequenced the bulk transcriptomes of cell populations, rather
than single cells, to maximize our ability to capture these
transcripts. AIRE transcripts were significantly upregulated in
sorted CCR7+ eTACs compared to cDCs (6.91 log-fold change,
adjusted p-value = 2.76 × 10−4). We compared the TRA
expression in eTACs with that of cDCs from 4 paired tonsil
donors, and used postnatal mTECs from 3 unrelated donors
as positive controls. Expressed genes were assigned a tissue-
restricted status using the tissue-specificity index calculated
as per Yanai et al. (14), and as described in materials and
methods. A comparison of the proportions of TRAs expressed by
each cell population indicated that eTACs do not preferentially
express these antigens beyond the extent expected in peripheral
tissues such as the pancreas or kidney (Figure 3A), and contrary
to mTECs in which enrichment was visible. This pattern of
expression was corroborated when we compared the whole
distribution of the tissue-specificity index between eTACs, cDCs,
and mTECs. We observed a clear and consistent shift toward
greater tissue-specific expression in mTECs, indicated by a
higher τ -index (see Materials and Methods), which was not
mirrored by eTACs (Supplementary Figure 4). By performing
principal components analysis (PCA) focused upon TRAs,
eTACs had greater transcriptomic similarity to cDCs than to
mTECs (Figure 3B), occupying a similar space along principal
component 1, which accounted for ∼60% of the variation. This
was also evident by Pearson correlation of TRA expression, with
eTACs and cDCs clustering into a single clade distinct from
mTECs (Figure 3C). The exact AIRE-dependence of TRAs in
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FIGURE 2 | AIRE is expressed by a CD45+MHCII+ dendritic cell population expressing CCR7 and CD127 (A) Gating strategy based upon CD45, MHCII, Lin (CD3,
CD19, TCRαβ, TCRγδ, CD123, CD14, CD16, CD94, CD34), and CCR7. Gating for eTAC (green) and CCR7-CD11c+ conventional DC (blue) are indicated
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FIGURE 2 | (B) Frequency of eTACs and cDCs as percentage of CD45+ lymphocytes from tonsil as gated in A (n = 10) (C) Histograms display levels of CD45,
CD127, and PDL1 in cDCs (blue line) and eTACs (filled green) compared to isotype (gray), representative of at least 10 donors (D) AIRE mRNA expression in tonsillar
pDCs (n = 5) and eTACs (n = 9), and postnatal thymic mTECs (n = 4) relative to tonsillar cDCs (n = 9), normalized to β-actin levels, (mean ± SD ns = not significant,
**p < 0.005, ***p < 0.005 by Kruskal-Wallis with Dunn’s multiple comparison to cDCs) (E–G) Flow cytometric analysis of expression of various monocyte [(E); orange]
(E), pDC [(F); purple] and cDC [(G); blue] markers by tonsil eTACs (filled green) compared to isotype (gray) (H) mRNA expression for E2-2, IRF4, IRF8, and BATF3 in
eTACs, pDCs, and cDCs (n = 3), normalized to β-actin levels (mean ± SD *p < 0.05, **p < 0.005, ***p < 0.005 by ANOVA with Tukey’s multiple comparisons test)
(I) Representative images of cDCs, pDCs, and eTACs from human tonsil imaged by electron microscopy. Scale bars of 1µM are shown. Bar graph indicates
percentage of cells in each subset with >3 filopodia. See also Supplementary Figures 2, 3.
human mTEC has not yet been established. However, using
known murine Aire-dependent TRAs (13) we observed the
almost complete absence of many homologous TRAs in human
eTACs (Figure 3D), whilst others were expressed at comparable
levels between cDCs and eTACs; these TRAs were much more
abundant in mTECs. Therefore, unlike in the thymus, AIRE
expression in peripheral antigen presenting cells identified here
was not associated with promiscuous gene expression of TRAs.
AIRE-Enriched CCR7+CD127+MHCII+
DCs Are Functional DCs With T Cell
Stimulatory Potential
To assess the functional capacity of eTACs, we assessed
expression of selected membrane and endosomal toll-like
receptors (TLR) and their stimulatory capacity. While TLR3, 4
and 7 were expressed by eTACs at the RNA level (Figure 4A),
stimulation of these TLRs by a cocktail of agonists (LPS, poly(I:C)
and R848) induced production of less IL-6, IL12p70, and IL-
8 compared to cDCs (Figure 4B). This was also true when
cells were non-specifically stimulated with PMA and ionomycin
(Supplementary Figure 5A), and was not due to a difference in
cell death (Supplementary Figure 5B).
Mixed lymphocyte reactions of either eTACs or cDCs with
allogeneic T cells demonstrated the ability of eTACs to stimulate
both CD4+ and CD8+ T cells, with robust proliferation of both,
comparable with induction levels by cDCs (Figure 4C).
Mouse eTACs have previously been reported to functionally
inactivate CD4+ T cells (12). We investigated cytokine
production during allogeneic co-culture of eTACs with naïve
CD4+ T cells compared to co-culture with cDCs. We did
not observe evidence for anergy with similar levels of IFNγ
induced by both eTACs and cDCs. Indeed higher levels of
IL-2 were produced during co-culture with eTACs. Levels of
IL-10 were highly variable, and neither type-2 IL-4 nor type-
17 IL-17A could be detected (Figure 4D). For co-cultures
with memory CD4+ T cells we utilized memory responses
induced by tetanus vaccination to mimic an antigen-specific
stimulation. Either eTACs or cDCs were pre-loaded with
tetanus toxoid before the addition of autologous memory CD4+
T cells, containing vaccine-induced tetanus-specific memory
responses. Following a 6-day co-culture, supernatants were
assessed for cytokine responses (Figure 4E). While IL-4 was
not detected in either co-culture, IFNγ, IL-17A, IL-2, and
IL-10 were induced to a similar level by T cells interacting
with either eTACs or cDCs, demonstrating the ability of
eTACs to present exogenous antigen and induce functional
responses in CD4+ T cells. We further tested the ability
of tetanus-specific memory CD4+ T cells to respond to re-
stimulation following interaction with eTACs. Following co-
culture with either tetanus toxoid-loaded eTACs or cDCs,
CD4+ T cells were re-sorted and stimulated with antigen-
bearing cDCs. After a further 4 day co-culture, CD4+ T cells
were assessed for functional capability by IFNγ production
following PMA + ionomcyin stimulation. We did not observe
any difference in the response of these memory CD4+
T cells following interaction with either eTACs or cDCs
(Supplementary Figure 5C). Thus, we can conclude that eTACs
are functionally equivalent to cDCs in their capacity to stimulate
both CD4+ naïve and memory responses, and do not induce an
anergic phenotype.
AIRE Is Expressed During DC Maturation
The surface phenotype of eTACs was highly similar to that
of mature DCs; in addition to expression of CCR7 and
PDL1, eTACs within both tonsils (Figure 5A) and thymus
(Supplementary Figure 2) displayed high levels of MHCII and
costimulatory molecules including CD40, CD80, and CD86.
Furthermore, eTACs showed specific expression of CCL19
mRNA (Figure 5B), a T cell chemoattractant associated with DC
maturation (15, 16).
To determine whether eTACs represent activated and mature
DCs, we compared the transcriptomes of eTACs and cDCs
with those of unstimulated and LPS-stimulated monocyte-
derived DCs (designated moDC), from Zaal et al. (17). After
controlling for experimental variation using surrogate variable
analysis, we compared these DCs to our tonsil-derived cDCs
and eTACs in a reduced dimensional space defined by PCA
(Figure 5C). As expected, cDCs were transcriptionally more
similar to unstimulated moDCs while eTACs were more
similar to the LPS-stimulated moDCs along the first major
axis of variation. These relationships were maintained in
higher dimensions, illustrated by the high correlations, and
co-clustering, between eTACs and the LPS-stimulated moDCs
(Figure 5D).
To determine when during the maturation process AIRE
might be expressed, we constructed a maturation trajectory
from our single-cell RNA-sequencing data of the wider
EpCAM+ sorted cells. Using a diffusion map, which defines
vectors through the high dimensional transcriptome space
via a diffusion process, cells were ordered according to
the transition probability of progressing from one cell to
another. Thus, this trajectory represents the underlying biological
progression from one cellular state to another. While analysis
of the single-cell RNA-sequencing data had demonstrated that
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FIGURE 3 | AIRE in peripheral dendritic cells is not associated with tissue-restricted antigen expression. Populations of eTACs (n = 4), cDCs (n = 4, paired donors)
and mTECs (n = 3, distinct donors) were sorted and the entire transcriptome sequenced as a bulk population, for detecting tissue-restricted antigen expression.
(A) Genes were assigned as tissue-restricted using the tissue-specificity index (see Materials and Methods). Proportions of expressed genes in this category in eTACs,
cDCs, and mTECs and in specific peripheral tissues are shown. (B) Principal components analysis of eTACs, cDCs, and mTECs samples using all expressed TRA
genes. Shown are the first 2 major components of variation, corresponding to 60.34 and 11.09% of the variance, respectively. (C) A heatmap illustrating the similarity
of cDCs, eTACs, and mTECs based on the Pearson correlation of expression of tissue restricted antigen genes. Dendrograms represent average-linkage hierarchical
clustering on the Pearson correlation values. (D) Log2 expression of genes homologous to AIRE-dependent TRAs identified in mice within bulk sequenced cDCs
(blue), eTACs (green), and mTECs (black). See also Supplementary Figure 4.
AIRE transcripts were enriched within CCR7+CD127+ cells,
transcripts were still expressed in only a proportion of cells
(23/151 cells; 15.2%) (Figure 1F). The inferred pseudotime
trajectory revealed two major branches (Figure 5E) from which
we identified four groups of cells as regions of greatest
cellular density using a K-means partitioning along pseudotime
(Figure 5E). The yellow branch of cells appeared to represent
monocytic cells, with significant upregulation of genes such as
CD14 and MMP9, but not AIRE (Supplementary Figure 6A)
and excluded from the refined phenotype of eTACs by
addition of CD14 in the lineage cocktail. Therefore, we
did not consider these further in our maturation trajectory
analysis.
On the other hand, AIRE expression was enriched in
the turquoise group of cells (Figure 5F) together with
upregulated expression of CCR7 and CCL19 (Figure 5F,
Supplementary Figures 6B,C), as observed previously. These
markers were also relatively enriched in the brown group of
cells, while CCR6–a chemokine receptor expressed in DCs
prior to CCR7 and downregulated upon migration to, and
maturation within, secondary lymphoid organs–was relatively
downregulated (Figure 5F). This suggests a development
trajectory in which DC maturation progresses from the
brown (more immature) to turquoise (more mature) group.
Interestingly, AIRE expression was concentrated toward the
terminal end of the pseudotime branch (turquoise cells)
(Figure 5G), indicating that AIRE expression is associated with
a more mature phenotype. Further, as indicated in Figure 5G,
levels of AIRE vary across this small number of cells, which
indicates that eTACs do not represent a stable sub-population of
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FIGURE 4 | Dendritic cells expressing AIRE can modulate T cell responses (A) mRNA expression of select TLRs in cDCs (blue) and eTACs (green) relative to β-actin
(n = 3) (mean± SD ns = not significant, *p < 0.05 by paired t-test) (B) cDCs or eTACs were stimulated with a cocktail of TLR stimuli; LPS plus poly(I:C) plus R848.
Concentrations (pg/ml) of IL-6, IL12p70, and IL-8 were determined in culture supernatants after 24 h (n = 3) (mean ± SD ns = not-significant, *p < 0.05 by paired
(Continued)
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FIGURE 4 | t-test) (C) Representative FACS plots of mixed lymphocyte reactions (MLR) of allogeneic CD4+ and CD8+ T cells 6 days after coculture with cDCs or
eTACs, proliferation was determined by CTV dilution and cumulative data plotted (n = 3) (mean ± SEM, ns = not-significant by paired t-test) (D) Concentration of
IFNγ, IL-4, IL-17A, IL-10, and IL-2 in 6 day culture supernatants from coculture of allogeneic naive CD4+ T cells with cDCs or eTACs (n = 3) N.D. indicates cytokines
not detected (*p < 0.05, ns = not-significant by paired t-test) (E) Concentration of IFNγ, IL-4. IL-17A, IL-10, and IL-2 in 6 day culture supernatants from coculture of
autologous memory CD4+ T cells with cDCs or eTACs loaded with tetanus toxoid. Dotted lines indicate concentration of each cytokine in the absence of tetanus
toxoid, which was <6 pg/ml in all cases (n = 6) N.D. indicates cytokines not detected (ns = not-significant by paired t-test). See also Supplementary Figure 5.
cells and is suggestive instead of transient expression. Together,
this would imply that eTACs represent a temporal state in the
maturation of DC migrating to secondary lymphoid organs,
such as lymph nodes and tonsils, and during which AIREmay be
transiently expressed.
DISCUSSION
The existence of a population of AIRE expressing cells outside
of the thymus has long been suggested, even from the first
identification of the AIRE gene (3). However, the identity of
this cell population—particularly in humans—has been elusive.
Here we identify AIRE expressing cells in human tonsils. Our
experimental investigations revealed AIRE to be expressed by
mature DC, characterized by high levels of antigen presentation
with reduced TLR responsiveness, and expression of both
CCR7 and PDL1. By single cell sequencing analysis we further
observed AIRE to be transiently expressed by this population
during their differentiation to a mature phenotype. Importantly,
and somewhat surprisingly, we found expression of AIRE in
the absence of enrichment in promiscuously-expressed TRAs.
The transient nature of AIRE expression, together with the
lack of TRAs, provides some explanation for the difficulty in
characterizing human eTACs to date.
eTACs were originally described in mice, with the aid of an
Aire-GFP reporter, yet even here their identification has not been
straightforward. eTACs in mice were first described as antigen-
presenting, non-hematopoietic, stromal cells (7), but later re-
defined as hematopoietic with low expression levels of CD45
(12). This low CD45 expression is thought to explain the prior
identification of AIRE in stromal populations, which could be
further confused by the expression of EpCAM, a marker of
eTACs in mice (12). While human AIRE+ cells were also CD45lo
and appeared to express EpCAM on the cell surface, we did
not detect transcripts for EpCAM in human AIRE+ cells of
either tonsil or thymus. Detection of EpCAM on these cells by
antibody-staining, here and in mice (12), may reflect acquisition
of EpCAM by a form of transfer, for example by exosome uptake
or membrane exchange. Indeed, mature DC within the thymus
have previously been described to acquire EpCAM, together
with other molecules, from neighboring thymic epithelial cells
(18, 19).
Instead, we found CCR7 to be the most specifically and
strongly up-regulated cell surface marker in AIRE-enriched
cells, at both the transcript and protein level. Sorting by this
marker lead to a much more profound enrichment in AIRE
than sorting by EpCAM. Further phenotyping demonstrated
that these cells express several DC markers in addition to
CD11c, including surface markers and transcription factors. This
description is supported by the immunohistochemical analyses
of human secondary lymph nodes, including tonsils, and gut-
associated lymphoid tissue by Poliani et al. (9) who found that
AIRE co-localized with HLA-DR and CD40, myeloid markers
such as CD11c, and, importantly, with CCR7. In addition,
these CCR7+CD127+MHCII+ cells displayed T cell stimulatory
capacity ex vivo in our experiments which, together with their
phenotype, led to their identification as a population of DCs.
Expression of CCR7 byDCs is associated with amigratory and
mature phenotype. Up-regulated expression of CCR7 and down-
regulation of tissue-homing receptors such as CCR6 are required
for migration and positioning of DC within secondary lymphoid
organs (20, 21). The AIRE-enriched cells identified here also
expressed the receptor for IL-7, CD127, which was absent from
cDCs. CD127 has previously been described to be specifically
expressed by migratory DC within mice, and thought to be
important for their positioning near IL-7 producing reticular
cells of the T cell zone (22); indeed we identified AIRE+ cells
within the T cell zones of the tonsils. Upon activation, DCs
also up-regulate MHCII and costimulatory molecules CD80
and CD86, and down-regulate CD11c (20). This maturation
process is in line with a switch in functional priorities from
antigen capture to antigen presentation. These findings are
consistent with the CD11cloMHCIIhiCD80hiCD86hi phenotype,
reduced TLR responsiveness and pro-inflammatory cytokine
production, and the more rounded, less dendritic morphology of
eTACs. While this phenotype may result from the inflammatory
environment from which these cells were isolated (the indication
for adenectomy being due to recurrent adenitis), we also
identified AIRE-expressing cells within the postnatal thymus,
under physiological steady state conditions, and, importantly,
these cells had the same phenotype. This included the specific
expression of CCR7, CD127, and PDL1. Together these results
suggest this phenotype is not simply a result of inflammation,
and may be indicative of a homeostatic maturation and/or
migration of DCs, with a fraction of DCs previously described
to undergo constitutive maturation (23). Interestingly TSLP, a
cytokine that also interacts with CD127, has been described
to activate thymic CD11c+CD11b- DCs. When treated with
TSLP these thymic DCs could stimulate Treg cells from CD4+
thymocytes but not from peripheral CD4+ T cells (24). Although
not directly analyzed, the ability to responsd to TSLP would
suggest expression of CD127 by these thymic DC, and therefore
it is tempting to speculate that the CCR7+ CD127+ AIRE+
DC that we identified in the thymus may be identical to these
TSLP-responsive DC.
While mature DCs within tonsils were enriched in AIRE
expression there was, however, a wide variation between donors,
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FIGURE 5 | AIRE is upregulated in mature dendritic cells (A) Flow cytometric analysis of antigen presenting and costimulatory molecules by tonsil eTACs (filled green)
and cDCs (blue line) compared to isotype (gray) (B) CCL19 mRNA expression in cDCs and eTACs (n = 3), normalized to b-actin levels (mean ± SD, *p < 0.05 by
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FIGURE 5 | paired t-test) (C) PCA analysis of the transcriptome of eTACs (green) and cDCs (blue) compared to unstimulated (orange; moDC Unstim) and LPS
stimulated (purple; moDC LPS) monocyte-derived DCs (Zaal et al.). The plotted axes are principal component 1 (PC1) and 2 (PC2) which together explain ∼50% of
the variation. The first (x) axis separates the stimulation profile. (D) Heatmap shows Pearson correlation values of 12 principal components, which capture >95% of
the total variation for eTACs, cDCs, unstimulated, and LPS-stimulated moDCs (E) Pseudotime analysis of single cells showing CCR7+ PDL1+ CD11clo cells on one
trajectory, plotting cells according to diffusion component (DC) 1 and 2, left. Right shows cell density along each branching trajectory, and colored accordingly (F)
Gene expression of select genes in the blue, brown, and turquoise meta-stable states along the first diffusion component (G) Log2 AIRE gene expression over the first
diffusion component, which represents the inferred pseudotime. The RUG plot below indicates which meta-stable state cells are assigned to, i.e., turquoise, brown,
blue, and yellow, as identified in E. Points are colored by log2 AIRE expression for emphasis. See also Supplementary Figure 6.
and single cell sequencing revealed AIRE to be expressed by only
a proportion of cells and at varying levels. Immunohistochemical
analyses, both here and in previous work (9, 12), identifed AIRE+
cells at a low frequency within secondary lymphoid organs in
humans. Furthermore, our pseudotime inference from the single
cell transcriptomes suggests that AIRE+ cells do not represent a
single stable population. This implies that AIRE expression does
not correspond to a distinct cell subset within tonsils, but rather
an intermediate cellular stage. The increased AIRE expression
together with increased CCR7 and PDL1, and decreasing CCR6,
expression would indicate that this state is associated with the
process of maturation. This is not without precedent, as thymic
B cells have been described to induce AIRE expression upon
signaling through CD40, with a concomitant up-regulation of
MHCII and CD80 (25). This raises the possibility that AIRE
expression may also be induced by CD40-mediated NF-κB
signaling in DCs, or potentially in only a subset of DCs resident
in peripheral lymphoid tissue. The prototypical AIRE expressing
cells in the thymus are the medullary epithelial cells (mTECs).
Amongst mTECs, AIRE expression is restricted to those bearing
a mature phenotype, a differentiation state defined by high
expression of MHCII and CD80 (1, 26) as well as expression
of PDL1 (27, 28). Therefore, the MHCIIhi, CD80hi, PDL1+
phenotype of AIRE-expressing DCs identified here by and large
mirrors that of AIRE-expressing mTECs. Furthermore, mTECs
are known to secrete CCL19 to attract immature thymocytes for
negative selection (29); CCL19 mRNA was specifically enriched
within the AIRE+ mature DCs. Furthermore, in mice, typically
only 50–60% of phenotypically mature mTECs express AIRE at
any one time (30). Moreoever, AIRE expression is also restricted
to a particular stage during mTEC differentiation from immature
epithelia to a post-mitotic, terminally differentiated cell stage
(26, 31).
Our observations raise the question of what role AIRE plays
within these DCs. Expression of AIRE during a maturation
process, rather than by a distinct subset, would imply a distinct
role for the AIRE gene during this process as opposed to a distinct
function of AIRE-expressing cells, and indeed we found AIRE-
enriched DC to possess the same T cell stimulatory capacity
as cDC without inactivation of CD4+ T cells as had been
observed previously (12). The assumption to-date has largely
been that AIRE is associated with expression of TRAs. While
this may be true within the thymus, it may not necessarily
be true for peripheral cells. Indeed, while identification of the
expression of AIRE-controlled TRAs in the thymus has been
reproduced across studies, reports within the periphery have
been less consistent (32). We found no evidence for an enriched
expression of TRA, or human homologs of known mouse Aire-
dependent TRAs, within humanAIRE+DCs. This would suggest
that AIRE might perform an alternative role within these cells.
Indeed, roles for AIRE in other cellular processes have been
described. For example, AIRE has been reported to promote
the expression of chemokines including CCL19 (33, 34)–a
chemokine which we found enriched in these cells. A central role
for AIRE in controlling the differentiation program of mTECs
toward terminal differentiation has also been reported (31).
Likewise, AIRE may be directly involved in the differentiation
process of DCs during maturation. Overexpression of AIRE
in a monocytic cell line induced changes consistent with the
maturation process of monocyte-derived DCs (35). Further,
monocyte-derived DCs of APECED patients, and thus lacking
functional AIRE, are functionally impaired (36). Indeed, not
all symptoms in these patients can be explained by a loss of
tolerance, such as an increased susceptibility to fungal infections.
Therefore, identification of human “eTACs” as maturing DCs
signifies an important step not only in understanding DC
biology, but in further understanding autoimmune and other
diseases such as APECED.
MATERIALS AND METHODS
Human Tissues
All tissues were used with approval of the Medical Ethical
Committee of the Academic Medical Center, Amsterdam
according to the Research Code of the Academic Medical
Center of the University of Amsterdam. Tonsils were obtained
from pediatric and adult tonsillectomies. Postnatal thymi were
obtained from surgical specimens removed from children up
to 3 years of age undergoing open heart surgery. Tissues were
disrupted by mechanical means and pressed through a stainless
steel mesh to obtain a single-cell suspension. Mononuclear
cells were isolated from a Ficoll–Hypaque density gradient
(Lymphoprep; Axis-Shield).
Cell Isolation
Tonsil mononuclear cells were depleted of T and B cells
by FITC-conjugated anti-CD3 (OKT3; BioLegend) and anti-
CD19 (HIB19; BioLegend) and anti- FITC microbeads (Miltenyi
Biotec) and passed over an LD magnetic column (Miltenyi
Biotec). Cells were subsequently sorted to purity using a
FACSAria (BD Biosciences) and antibodies against lineage
(CD3, CD19, CD20, CD94, CD34, CD16, CD14, TCRαβ,
TCRγδ), HLA-DR, CD11c, CCR7, CD123, and BDCA2. eTACs
were sorted as Lin-CD123-BDCA2-HLADR+CCR7+, cDCs
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as Lin-CD123-BDCA2-HLADR+CD11c+ and pDCs as Lin-
HLADR+CD123+BDCA2+. Cells were incubated with an FcR
block (Miltenyi Biotec) prior to antibody staining.
T cells were FACS sorted directly from mononuclear cells
using antibodies against CD4, CD8, CD45RO, and CD25. For
mixed lymphocyte reactions equal numbers of CD4+CD8-
CD25- and CD4-CD8+CD25- cells were sorted. Memory CD4+
T cells were sorted as CD4+CD8-CD45RO+CD25-. Staining of
CD3 was omitted to prevent potential cross-linking and signaling
via CD3.
For isolation of mTEC postnatal thymic tissue was cut
into small pieces and digested for 1 h at 37◦C with IMDM
(GIBCO) containing Liberase TM (125µg/ml). The resulting cell
suspension was passed through a 70µm cell strainer and then
epithelial cells selected using anti-EpCAM microbeads (Miltenyi
Biotec) as per themanufacturer’s recommendations. mTECs were
further selected from the positive fraction as CD45−CD80+HLA-
DR+EpCAM+ cells by flow cytometric cell sorting.
Antibodies
Antibodies were used as detailed in Supplementary Table S1.
Dead cell discrimination was performed using live/dead fixable
green dead cell stain kit (Life Technologies). Data was analyzed
with FlowJo software version 10 (FlowJo, LLC).
CyTOF
Directly conjugated antibodies were purchased from
Fluidigm, or MaxPar-ready antibodies purchased from
BioLegend and conjugated following Fluidigm’s Lanthanide
Labeling of Antibodies Pre-Load method with X8 polymers.
Conjugated antibodies were stored in Antibody Stabilizer
(Candor Biosciences). Antibodies used are shown in
Supplementary Table S2.
First, tonsil cells were depleted of T (CD3) and B (CD19)
cells as previously, and left overnight at 4 degrees. The next
day, cells from 2 donors were pooled and resuspended in a
Cell-ID Cisplatin viability stain (Fluidigm) at 5µM for 5min at
room temperature. Fc receptors were then blocked by a 10min
incubation at room temperature with FcR block (BioLegend)
before addition of surface antibodies for a further 30min. Cells
were washed twice with staining buffer (PBS + 1% BSA) and
incubated overnight in 250 nm of Cell-ID intercalator (Fluidigm)
in 2% paraformaldehyde (Pierce). Before acquiring cells were
washed extensively in staining buffer, PBS and distilled water, and
EQ Four Element Calibration beads added (Fluidigm). CyTOF
data were acquired on-the-fly, using dual-count mode and noise-
reduction on. All other settings were either default settings or
optimized with tuning solution, as instructed by Fluidigm. After
data acquisition, the mass bead signal was used to normalize
the short-term signal fluctuations. Analyses were performed with
Cytobank (37).
Co-cultures
All cells were cultured in Yssel’s medium supplemented with
3% (vol/vol) heat inactivated normal human AB serum. eTAC
or cDC were cocultured with T cells at a 1:2 ratio. In specific
experiments T cells were stained with Cell Trace Violet (Thermo
Fisher Scientific) at a concentration of 5µM before coculture. In
antigen-specific experiments, eTAC or cDC were first incubated
with 10µg/ml of tetanus toxoid (Calbiochem) before addition
of autologous memory CD4+ T cells. All cocultures were
performed for 6–7 days.
Cytokine Measurements
For detection of intracellular cytokines, cells after coculture
were activated with PMA (50 ng/ml; Sigma) and ionomycin
(1µM;Merk) for 6 h in the presence of GolgiPlug (1 µl/ml BD
Biosciences) for the final 4 h. Cytokines in coculture supernatants
were analyzed by LEGENDplex Th cytokine panel (BioLegend).
For activation of eTAC, cDC and pDC, purified subsets
were cultured at 5 × 103 cells per well in the presence of
LPS (100 ng/ml; Sigma), poly(I:C) (25µg/ml;Sigma) and R848
(25µg/ml; Invivogen), or with PMA (50 ng/ml; Sigma) and
ionomycin (1µM;Merk). Culture supernatants were harvested
after 24 h and analyzed by a custom LEGENDPlex human
inflammation panel (BioLegend).
Quantitative Real-Time PCR
Total RNA was isolated from sort-purified cells with NucleoSpin
RNA XS kit (Macherey-Nagel) according to the manufacturer’s
protocol. Complementary DNA was synthesized with the High-
Capacity cDNA reverse transcription kit (Applied Biosystems).
Quantitative real-time PCR was performed on a C1000 Thermal
cycler CFX96 real-time system (Biorad) with IQ SYBR Green
supermix (Bio-Rad). Primers sets used were:
β-actin forward 5′-CACCATTGGCAATGAGCGGTTC-3′,
reverse 5′-AGGTCTTTGCGGATGTCCACGT-3′ ; AIRE
forward 5′-GAGAGTGCTGAGAAGGACA-3′, reverse 5′-GTT
TAATTTCCAGGCACATGA-3′ ;
E2-2 forward 5′-GCCTCTTCACAGTAGTGCCAvTG-3′,
reverse 5′-GCTGGTTTGGAGGAAGGATAGC-3′ ;
IRF4 forward 5′-TGATCGACCAGATCGACAGC-3′, reverse
5′-GGGGCACAAGCATAAAAGGT-3′ ;
IRF8 forward 5′-TGGGGATGATCAAAAGGAGCC-3′, reverse
5′-AACTGGCTGGTGTCGAAGAC-3′ ;
BATF3 forward 5′-GAGCCCTGAGGATGATGACAG-3′,
reverse 5′-CTTCCCGATCTCTCTCCGCA-3′;
CCL19 forward 5′-CCTCAGCCTGCTGGTTCTCT-3′, reverse
5′-CAGCAGTCTTCAGCATCATTGG-3′;
TLR3 forward 5′-TTGCCTTGTATCTACTTTTGGGG-3′,
reverse 5′-TCAACACTGTTATGTTTGTGGGT-3′;
TLR4 forward 5′- AGACCTGTCCCTGAACCCTAT-3′, reverse
5′- CGATGGACTTCTAAACCAGCCA-3′;
TLR7 forward 5′-TCCTTGGGGCTAGATGGTTTC-3′, reverse
5′-TCCACGATCACATGGTTCTTTG-3′;
TLR9 forward 5′-CTGCCACATGACCATCGAG-3′, reverse 5′-
GGACAGGGATATGAGGGATTTGG-3′;
EpCAM forward 5′-TTTGCGGACTGCACTTCAGA-3′,
reverse 5′-AAGATGTCTTCGTCCCACGC-3′.
Immunostaining
Cryopreserved tonsil sections were thawed and fixed with
acetone for 10min. Subsequently, slides were washed 3 times
with PBS and primary antibody (anti-AIRE: D17 and anti-CD19:
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HIB19 Santa Cruz) was incubated overnight in 1% (w/v) bovine
serum albumin (BSA) in PBS at 4◦C. After, slides were washed
3 times with PBS and secondary antibody (Alexa Fluor 594
donkey anti-goat: A11058 and Alexa Fluor 488 donkey anti-
mouse: A21202, Invitrogen) was diluted in 1% BSA, 10% (v/v)
donkey serum (Jackson Immuno Research Inc.: 017-000-121)
in PBS. Incubation with secondary antibody was 1 h at room
temperature after which the slides were washed 3 times with PBS.
Finally, the slides were mounted with ProLong Gold Antifade
Mountant (Invitrogen). Stained slides were imaged using a Leica
TCS SP8 X Confocal Microscope (Leica, Wetzlar, Germany).
Images were captured by using Leica software.
Electron Microscopy
Directly after sort purification cells were fixed in 1%
glutaraldehyde and 4% PFA in 0.1M sodiumcacodylate buffer
(McDowell fixative) and post-fixed with 1% osmiumtetroxide
(OsO4, Electronmicroscopy sciences, Hatfield, PA, USA) in
water. Subsequently, the samples were dehydrated in an alcohol
series and embedded into Epon (LX-112 resin Ladd research,
Williston, VT, USA). Ultrathin epon sections were collected
on formvar-coated grids, counterstained with uranyl acetate
and lead citrate and visualized with a transmission electron
microscope (FEI Tecnai 12). Images were taken from each subset
and organelles quantified in a blinded manner.
Single-Cell RNA Sequencing
CD45+HLADR+CD127+CD40+EpCAM+ cells were sorted
as single cells into wells of a 384 well-containing lysis buffer
and ERCC92 RNA at a dilution of 1:1,000,000 of mix 1 per
well (ThermoFisher). Single cell cDNA was generated using the
SMARTSeq2 protocol (38), and multiplexed libraries for high
throughput sequencing were generated using the Nextera XT
preparation (Illumina). Multiplexed libraries were sequenced on
a HiSeq 2500 to generate 150 bp paired end (PE) reads.
Single Cell RNA Sequencing Processing
Defined contaminating sequencing and library preparation
adaptors were removed from single cell RNA-seq reads using
trimmomatic (-a AGATCGGAAGAGC –overlap 18 –minimum-
length 25 –maximum-length 28 -q 20) (39). Trimmed reads
were aligned to the Homo sapiens genome (hg38) concatenated
with the ERCC92 sequences using STAR v4.2 (40), requiring
≥95% of bases to align perfectly to the reference genome
(–outFilterType BySJout –outSAMattributes All). Single cell
alignments were deduplicated using Picard ToolsMarkDuplicates
(http://broadinstitute.github.io/picard/), prior to quantification
of protein-coding gene expression using featureCounts (41),
summarized at the gene level using the Homo sapiens Ensembl
build 86 as a reference (42).
Single Cell RNA Sequencing Quality
Control
The quality of single cells was assessed based on the total number
of reads, the number of genes detected per cell as well as the
percentage of expression attributable to the ERCC spike-in genes.
Poor quality cells were removed on the basis of the following
filters; total unique reads <100 k, < 1000 genes expressed and
sparsity>95% (number of 0-counts across all genes). In total 217
cells passed quality control measures and were used for further
analysis.
Normalization of Single Cell Gene
Expression and Definition of Highly
Variable Genes
Genes that displayed high sparsity of expression across cells
(>95% 0-counts) were removed, and cell-specific size factors
were estimated using the deconvolution method (43). Gene
expression counts were normalized by these size factors prior to
a log2 transformation, implemented in the Bioconductor package
scran (43). Highly variable genes (HVGs) were defined across all
217 cells by fitting the squared coefficient of variation (CV2) to
the mean log2 expression, parameterized as in Brennecke et al.
(44). Genes were tested for excessive deviation from the expected
trend using aχ2 test. Genes with a p-value≤ 0.01 were designated
as highly variable, resulting in 128 HVGs.
Dimensionality Reduction and Visualization
of Single Cells
High dimensional single cell transcriptomes were visualized
using dimensionality reduction techniques. Principal
components analysis, using the centered and scaled log2
expression values, was used to visualize the major axes of
variation through the single cell transcriptome data. The
high dimensional embedding of cells into 2 dimensions was
performed using t-distributed stochastic neighbor embedding
(tSNE) (45), with the 128 HVGs and a perplexity value set to 50,
implemented in the R package Rtsne.
Single Cell Clustering
Assignment of single cells to discrete clusters was performed
by first calculating the Spearman correlation dissimilarity (1–
ρ), which was used as input to hierarchical clustering using
the average linkage algorithm. Clusters were defined using the
dynamic tree cutting algorithm (minimum module size 30 cells),
implemented in the Bioconductor package WGCNA (46). Cell
similarities were visualized in heatmaps using the pheatmap
package in R (47).
Single Cell Pseudotime Inference
The maturation trajectory of single cells was inferred from
the diffusion map constructed on the HVGs defined above.
Specifically, the first 3 eigenvalues from the cosine normalized
gene expression matrix were used to construct the diffusion map
across cells (k = 21), implemented in the Bioconductor package
destiny (48, 49). Meta-stable states along the inferred pseudotime
were assigned using a k-means partitioning of the first diffusion
component into 4 clusters, implemented in R (47).
Single Cell Differential Expression Testing
Differentially expressed genes were tested between defined
groups (e.g., clusters, meta-stable states, etc. ) by fitting a
generalized linear model to the average log2 expression values,
blocking on potential nuisance factors, cell plate position (by
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column) and donor. Empirical Bayes shrinkage of the log fold
change estimates was performed prior to formal differential
expression testing against a null hypothesis of no difference in
log2 fold changes by a moderated t-test, implemented in the
Biconductor package limma (50). Differentially expressed genes
were defined based on a false discovery rate (FDR) of 1% for each
analysis.
Tissue Restricted Antigen Definition
Cap analysis of gene expression (CAGE) with high throughout
sequencing (CAGE-seq) run length normalized (RLE) tag
expression data were downloaded from the FANTOM5
consortium website (URL). The human samples were manually
placed into 107 tissue groups. Tissue specificity of gene
expression was calculated across these 107 tissue groups using
the τ -index as per (14). Specifically the τ -index is calculated per
gene as follows:
τ =
∑N
i= 1 (1− xi)
N − 1
Where xi is the expression of gene x in tissue i ∈ {1, 2, . . .N}.
Genes with a τ -index value ≥ 0.8 were assigned tissue restricted
antigen (TRA) genes, whilst those with a τ -index ≤ 0.4 were
assigned to the constitutively expressed group. All other genes
were placed into theMiscellaneous category.
Bulk RNA Sequencing
CD45+Lin-HLADR+CD11c+ cDC and CD45+Lin-
HLADR+CCR7+ eTAC were sorted from the tonsils of 3
donors directly into Trizol Reagant. Likewise, mTEC were sorted
as CD45-HLADR+CD80+EpCAM+ cells from 3 separate
donors. Total RNA was extracted using TRIzol reagent (15596-
018, Ambion life technologies) according to the manufactures
protocol. Briefly, 0.2 × volumes of chloroform (Chloroform
stab./Amylene, Biosolve) was added to the homogenate and the
tube(s) were shaken vigorously. The tube(s) were incubated for
2–3min at room temperature and centrifuged (Hettich, rotanta
46 RS) for 1 h (4120 RCF, 4◦C). Approximately 70% of the upper
aqueous phase was transferred to a clean 15mL tube with the
addition of 1 µl of glycogen (20 µg/µL) (10814-010, Invitrogen)
and 0.5 ×volume of isopropanol (33539, Sigma-Aldrich, ) was
added. The tube(s) were incubated overnight at −20◦C and
centrifuged for 30min (4120 RCF, 4◦C). The supernatant was
removed and the pellet was washed twice with 80% ethanol
(32221-2.5L, Sigma-Aldrich). The total RNA pellet was air-dried
for 8min and dissolved in an appropriate volume of nuclease
free water (AM9937, Ambion life technologies) and quantified
using the Nanodrop UV-VIS Spectrophotometer (Thermo
Fisher Scientific Inc.). Quality and quantity of the total RNA
was assessed by the 2100 Bioanalyzer using a Pico chip (Agilent,
Santa Clara, CA).
TruSeq RNA Access Sample Preparation
Strand-specific libraries were generated using the TruSeq RNA
access sample preparation kit according to the manufacturer’s
instructions (Illumina, Part # 15049525 Rev. B). The FF RNA
was fragmented, random primed and reverse transcribed using
SuperScript II Reverse Transcriptase (Invitrogen, part # 18064-
014) with the addition of Actinomycin D. Second strand
synthesis was performed using Polymerase I and RNaseH with
replacement of dTTP for dUTP. The generated cDNA fragments
were 3’ end adenylated and ligated to Illumina sequencing
adapters and subsequently amplified by 15 cycles of PCR. The
libraries were analyzed on a 2100 BioAnalyzer using a 7500
chip (Agilent, Santa Clara, CA). Capture pools of 200 ng
per sample were compiled based on library yield and unique
adapter sequence, where after target enrichment of the exome
is performed. The captured fragments were amplified by a 2nd
amplification of 10 PCR cycles. The captured fragments were
assessed on a 2100 BioAnalyzer, diluted and equimolar pooled
into a 10 nM multiplex sequencing pool, containing 12 samples
per pool.
Sequencing
The libraries were sequenced SR65 using one sequencing lane
per pool on a HiSeq2500 with V4 chemistry (Illumina Inc., San
Diego). The reads were aligned against the human transcriptome
(hg38) using Tophat2 (Tophat version 2.1.0 / Bowtie version
1.1.0) that allows for exon-exon junctions (51, 52). Tophat
was guided using a reference genome as well as a reference
transcriptome. The reference transcriptome was created using
a gene transfer file (GTF) that was downloaded from Ensembl
(version 77). Genecounts were generated using Icount, which is
based on HTSeq-count (53). Only reads that mapped uniquely
to the transcriptome were used to determine the number of reads
per gene. The strandedness of the fragments generated during the
library preparation was taken into account for both the alignment
and the determination of the genecounts.
Tissue Restricted Antigen Detection
Sensitivity
The aligned reads (BAM file) for each individual sample of
mTECs, cDCs, and eTACs were randomly down-sampled to
∼20M reads using samtools (54). Down-sampled BAM files were
used to quantify gene expression of all hg38 Ensembl build 86
protein-coding genes using featureCounts (41).
Bulk RNA-seq Normalization and
Differential Expression Testing
Count matrices (genes X samples) were normalized between
samples using size factors as described in Anders et al. (55),
prior to a log2 transformation using a constant offset of 1. Gene
count tables were downloaded through the GTEx portal (https://
www.gtexportal.org/home/), and 3 samples were randomly
selected from the kidney, pancreas and brain cortex samples.
Samples were individually normalized using size factors as
described above, prior to a log2 transformation using a constant
offset of 1.
Functional Enrichment Testing
Functional enrichment testing was carried out on each gene set
using the Bioconductor package goseq (56). The Gene Ontology
Biological Process definitions were used for testing, corrected
for gene length bias in all analyses. Statistically significant
enrichments were called after multiple testing correction using
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the Benjamini and Hochberg method, at a false discovery rate
(FDR) of 1% (57).
CODE AVAILABILITY
All code used to analyse bulk and single-cell RNA-sequencing
data, and used to generate figure panels are available at https://
github.com/MikeDMorgan/Human_eTAC2018.
DATA AVAILABILITY
Single cell gene expression data are available through
ArrayExpress under accession E-MTAB-7381, and bulk
RNA-sequencing gene expression data are available through
accession E-MTAB-7383.
ETHICS STATEMENT
This study was carried out in accordance with the
recommendations of Research Code of the Academic Medical
Center of the University of Amsterdam with written informed
consent from all subjects. All subjects gave written informed
consent in accordance with the Declaration of Helsinki.
The protocol was approved by the Medical Ethical Review
Committee.
AUTHOR CONTRIBUTIONS
JF designed, performed and analyzed experiments, and wrote
the manuscript. MM performed all bioinformatic analyses
and wrote the manuscript. MB designed experiments. BH
performed experiments. VvU and FK provided essential CyTOF
support and experimental design. LH, JPvH and ST performed
immunohistochemistry. NvdW and DP performed electron
microscopy. MA provided essential guidance and discussion. JM
provided bioinformatics supervision. GH provided supervision,
discussion and guidance. HS performed overall study supervision
and design.
FUNDING
JF and HS were funded by project ERC-2013-ADG number
341038. MB was funded by EMBO ALTF 786-2013. BH
was supported by the Netherlands Organization for Scientific
Research (NWO) Veni program (91618032). LH, JpvH, and
ST were supported by a grant from the Dutch Arthritis
Foundation (2013_2_37). MMwas supported byWellcome Trust
(grant105045/Z/14/Z). JM was supported by core funding from
the European Molecular Biology Laboratory and from Cancer
Research UK (award number 17197).
ACKNOWLEDGMENTS
We would like to thank the Genomics Core Facility at the
Netherlands Cancer Institute for the RNA Sequencing of bulk cell
populations. We are also very grateful to B. Hooibrink, T. van
Capel and K. Brandwijk for assistance with flow cytometry and
cell sorting.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fimmu.
2018.02902/full#supplementary-material
Supplementary Figure 1 | Single cell RNA sequencing of tonsil cells reveals
AIRE expressing cells. Related to Figure 1. (A) Human thymus section stained by
immunofluorescence for DAPI (blue) and AIRE (red), scale bar indicating 10µM is
shown (B) Gating strategy of putative eTACs from tonsil cells depleted of T (CD3)
and B (CD19) cells for sorting as single cells for RNA seq analysis (C) Log10 total
read counts of all cells according to donor (A; green B; purple) (D) t-SNE plot of
single cells from Figure 1E colored according to donors as in b, above (E)
Heatmap of the top 75 genes with the strongest influence on separating cluster 1
(blue) and cluster 2 (orange) as shown in Figure 1E and clustered by hierarchical
clustering (F) MA plot differential expression testing between clusters identifies
CCR7 and CD11c as principal markers of these different DC populations. Plotted
are the mean log2 gene expression values (x-axis) against the log2 fold change
between clusters. Points below the horizontal are up-regulated in cluster 1 (blue),
and those above the horizontal are up-regulated in cluster 2 (orange). Points are
colored based on a 1% FDR (red: null hypothesis rejected, gray: failed to reject
null hypothesis).
Supplementary Figure 2 | AIRE expressing cells with equivalent phenotype, and
distinct from mTECs, can also be found within human thymus. Related to
Figure 2. (A) AIRE mRNA expression in tonsillar eTACs sorted as per Figure 2A
(CCR7+ “eTAC) or Supplementary Figure 1A (EpCAM+ “eTAC) relative to
tonsillar cDCs, normalized to β-actin levels (n = 6) (B) Gating strategy for the
isolation of mTECs from postnatal human thymus (PNT) (C) Identification of a
CCR7+ population amongst CD45+Lin-MHCII+ in PNT (D) Histograms show
levels of selected markers in CCR7+ intrathymic AIRE expressing cells (iTACs;
filled green) and cDCs (blue line) compared to isotype (gray) (E) AIRE mRNA
transcript levels in iTACs relative to thymic DCs, and normalized to β-actin (F)
Histograms indicate levels of antigen presenting and co- stimulatory molecules in
iTACs (filled green), thymic DCs (blue line) compared to isotype (gray) (G) EpCAM
mRNA transcript levels in iTACs and mTECs relative to β-actin (n = 3), ND,
non-detectable.
Supplementary Figure 3 | Morphology. Related to Figure 2. (A) Example
images and numbers of lipid bodies, multivesicular bodies and mitochondria were
counted in cells imaged by electron microscopy, (B) the percentage of dense
(closed) chromatin was estimated for each cell, (C) human tonsil sections stained
by immunofluorescence for DAPI (blue) and AIRE (green).
Supplementary Figure 4 | Tau-index analysis of TRA enrichment. Related to
Figure 3. Kernel density plot of Tau-Index in eTACs (green line), cDCs (blue line)
compared to mTECs (black line).
Supplementary Figure 5 | T cells stimulated with eTACs are still functional to
produce IFNγ. Related to Figure 4. (A) cDCs or eTACs were left unstimulated or
stimulated with PMA + Ionomycin and concentrations (pg/ml) of IL-6, IL12p70,
and IL-8 were determined in culture supernatants after 24 h (n = 3) (mean ± SD
ns = not significant, ∗p < 0.05 by paired t-test) (B) Percentages of live cells
amongst sorted eTACs (green) or cDCs (blue) after stimulation with TLR stimuli
(LPS plus poly(I:C) plus R848), PMA + Ionomycin or left unstimulated for 24 h (C)
Representative flow cytometry plots of PMA+ionomycin-stimulated memory
CD4+ T cells restimulated with autologous tetanus-toxoid loaded cDCs after
coculture with either eTACs or cDCs as in Figure 4E. Representative of 3
independent experiments.
Supplementary Figure 6 | Pseudotime-dependent gene expression analysis.
Related to Figure 5. (A) MA-plot of genes differentially expressed between (A)
yellow and blue, (B) brown and blue, and (C) turquoise and blue cell partitions
from the inferred pseudotime trajectory in Figure 5E. Points in red are statistically
significantly expressed (FDR 1%). Genes are labeled with a log2 fold
change >6.
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